• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Evofem Biosciences, Inc. - Common Stock (OP:EVFM)

    0.0094 -0.0007 (-6.93%)
    Streaming Delayed Price Updated: 3:24 PM EDT, Oct 24, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 328,147
    Open 0.0101
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0101
    Today's Range 0.0091 - 0.0120
    52wk Range 0.0061 - 0.0160
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MLNK, BFIN, MRCC, EVFM on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    Evofem Revenue Jumps 16 Percent in Q2
    Via The Motley Fool

    Performance

    YTD
    -2.1%
    -2.1%
    1 Month
    -33.8%
    -33.8%
    3 Month
    -3.1%
    -3.1%
    6 Month
    +3.3%
    +3.3%
    1 Year
    -2.1%
    -2.1%

    More News

    Read More
    TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Appoints Evofem CEO Saundra Pelletier to Board of Directors
    Via Investor Brand Network
    BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX) Appoints Evofem CEO Saundra Pelletier to Board of Directors
    Via Investor Brand Network
    EVFM Stock Earnings: Evofem Biosciences Reported Results for Q2 2024
    Via InvestorPlace
    Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials
    From Aditxt, Inc.
    Via Business Wire
    Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
    From Aditxt, Inc.
    Via Business Wire
    BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX) Gains Support for Evofem Merger as Voting Agreements Secure Favorable Votes
    Via Investor Brand Network
    Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem
    From Aditxt, Inc.
    Via Business Wire
    Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time
    From Aditxt, Inc.
    Via Business Wire
    Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives
    From Aditxt, Inc.
    Via Business Wire
    InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Moves Closer to Evofem Acquisition with Final Investment Milestone
    Via Investor Brand Network
    Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem
    From Aditxt, Inc.
    Via Business Wire
    Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time
    From Aditxt, Inc.
    Via Business Wire
    InvestorNewsBreaks – Aditxt (NASDAQ: ADTX), Evofem Announce Completion of Third Parent Equity Investment Under Amended Merger Agreement
    Via Investor Brand Network
    InvestorNewsBreaks – Gaxos.ai Inc. (NASDAQ: GXAI) Announces Participation at the Upcoming Game Industry Conference
    Via Investor Brand Network
    Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem
    From Aditxt, Inc.
    Via Business Wire
    InvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Releases Shareholder Update, Plans for Remainder of 2024
    Via Investor Brand Network
    Aditxt Delivers Shareholder Update and 2024 Year-End Plan
    From Aditxt, Inc.
    Via Business Wire
    InvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Acquisition Target Files Preliminary Proxy Seeking Stockholder Approval
    Via Investor Brand Network
    Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt
    From Aditxt, Inc.
    Via Business Wire
    InvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Subsidiary Signs Agreement with Evofem Biosciences Inc. (OTCQB: EVFM) Involving Unique Endometriosis Diagnostic Test
    Via Investor Brand Network
    Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025
    From Aditxt, Inc.
    Via Business Wire
    Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024
    From Aditxt, Inc.
    Via Business Wire
    Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024
    From Aditxt, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Evofem Biosciences, Inc. - Common Stock publicly traded?
    Yes, Evofem Biosciences, Inc. - Common Stock is publicly traded.
    What exchange does Evofem Biosciences, Inc. - Common Stock trade on?
    Evofem Biosciences, Inc. - Common Stock trades on the OTC Traded
    What is the ticker symbol for Evofem Biosciences, Inc. - Common Stock?
    The ticker symbol for Evofem Biosciences, Inc. - Common Stock is EVFM on the OTC Traded
    What is the current price of Evofem Biosciences, Inc. - Common Stock?
    The current price of Evofem Biosciences, Inc. - Common Stock is 0.0094
    When was Evofem Biosciences, Inc. - Common Stock last traded?
    The last trade of Evofem Biosciences, Inc. - Common Stock was at 10/24/25 03:24 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.